Montelukast: UK regulator says asthma drug needs clearer warnings of side effects
The asthma drug montelukast (Singulair) will carry more prominent warnings in the UK to alert doctors and patients to its potentially serious behavioural and neuropsychiatric side effects. Previously noted side effects associated with the oral treatment …